Business Description
StemCyte International Ltd
ISIN : KYG8477S1084
Description
StemCyte International Ltd is engaged in developing new stem cell drugs and test, process, and store umbilical cord blood (UCB)-related cells. The company's main operating activities are providing umbilical cord blood collection, processing and storage services. Its reportable segments are the United States, Taiwan, and Others. The majority of revenue is derived from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.85 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -2.16 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.2 | |||||
3-Year EBITDA Growth Rate | -0.9 | |||||
3-Year EPS without NRI Growth Rate | -4.2 | |||||
3-Year FCF Growth Rate | 0.8 | |||||
3-Year Book Growth Rate | 69.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.07 | |||||
9-Day RSI | 52.27 | |||||
14-Day RSI | 50.65 | |||||
3-1 Month Momentum % | -1.84 | |||||
6-1 Month Momentum % | -33.75 | |||||
12-1 Month Momentum % | -29.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.8 | |||||
Quick Ratio | 9.15 | |||||
Cash Ratio | 8.7 | |||||
Days Inventory | 603.17 | |||||
Days Sales Outstanding | 107.06 | |||||
Days Payable | 59.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.39 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.43 | |||||
Operating Margin % | -62.42 | |||||
Net Margin % | -50.16 | |||||
EBITDA Margin % | -27.91 | |||||
FCF Margin % | -22.15 | |||||
OCF Margin % | -21.8 | |||||
ROE % | -10.47 | |||||
ROA % | -5.87 | |||||
ROIC % | -24.51 | |||||
3-Year ROIIC % | -1047.34 | |||||
ROC (Joel Greenblatt) % | -25.77 | |||||
ROCE % | -5.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 9.93 | |||||
PB Ratio | 2.09 | |||||
Price-to-Tangible-Book | 2.1 | |||||
EV-to-EBIT | -12.52 | |||||
EV-to-EBITDA | -20.44 | |||||
EV-to-Revenue | 5.71 | |||||
EV-to-FCF | -25.76 | |||||
| Price-to-Net-Current-Asset-Value | 2.89 | |||||
| Price-to-Net-Cash | 4.99 | |||||
Earnings Yield (Greenblatt) % | -7.99 | |||||
FCF Yield % | -2.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
StemCyte International Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 357.737 | ||
| EPS (TTM) (NT$) | -0.93 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 39.49 | ||
| 14-Day RSI | 50.65 | ||
| 14-Day ATR (NT$) | 0.79411 | ||
| 20-Day SMA (NT$) | 18.41 | ||
| 12-1 Month Momentum % | -29.36 | ||
| 52-Week Range (NT$) | 16.6 - 33.95 | ||
| Shares Outstanding (Mil) | 214.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
StemCyte International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
StemCyte International Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
StemCyte International Ltd Frequently Asked Questions
What is StemCyte International Ltd(TPE:4178)'s stock price today?
The current price of TPE:4178 is NT$18.40. The 52 week high of TPE:4178 is NT$33.95 and 52 week low is NT$16.60.
When is next earnings date of StemCyte International Ltd(TPE:4178)?
The next earnings date of StemCyte International Ltd(TPE:4178) is .
Does StemCyte International Ltd(TPE:4178) pay dividends? If so, how much?
StemCyte International Ltd(TPE:4178) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on StemCyte International Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers